An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...
TOBY’s urine-based MCED test received FDA Breakthrough Device Designation. This is the first urine-based MCED platform ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and ...
Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results